Shijiazhuang Yiling Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd cash flow-to-debt ratio. Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has a Cash Flow-to-Debt Ratio of 0.13x as of September 2025, meaning its operating cash flow of CN¥446.51 Million could theoretically repay 0% of its total liabilities (CN¥3.52 Billion) in one year. Check 002603 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2025)
Cash flow-to-debt ratio of Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2025. Historical debt coverage capacity for Shijiazhuang Yiling Pharmaceutical Co Ltd across 18 annual periods. Check Shijiazhuang Yiling Pharmaceutical Co Lt (002603) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Shijiazhuang Yiling Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2008–2025)
Shijiazhuang Yiling Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2008 to 2025. Year-by-year debt coverage analysis for Shijiazhuang Yiling Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 002603 cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.66x | CN¥1.78 Billion | CN¥2.69 Billion | ▲ +236.5% |
| 2024 | 0.20x | CN¥611.01 Million | CN¥3.12 Billion | ▲ +598.7% |
| 2023 | 0.03x | CN¥155.46 Million | CN¥5.54 Billion | ▼ -95.6% |
| 2022 | 0.64x | CN¥3.49 Billion | CN¥5.41 Billion | ▲ +367.3% |
| 2021 | 0.14x | CN¥528.69 Million | CN¥3.83 Billion | ▼ -77.5% |
| 2020 | 0.61x | CN¥1.59 Billion | CN¥2.58 Billion | ▲ +894.3% |
| 2019 | 0.06x | CN¥68.93 Million | CN¥1.12 Billion | ▼ -15.3% |
| 2018 | 0.07x | CN¥72.37 Million | CN¥993.56 Million | ▼ -50.7% |
| 2017 | 0.15x | CN¥114.65 Million | CN¥775.58 Million | ▼ -78.7% |
| 2016 | 0.69x | CN¥641.45 Million | CN¥925.04 Million | ▲ +362.5% |
| 2015 | 0.15x | CN¥131.88 Million | CN¥879.56 Million | ▼ -5.0% |
| 2014 | 0.16x | CN¥105.90 Million | CN¥671.19 Million | ▲ +14.0% |
| 2013 | 0.14x | CN¥55.32 Million | CN¥399.69 Million | ▼ -36.7% |
| 2012 | 0.22x | CN¥70.13 Million | CN¥320.75 Million | ▲ +128.0% |
| 2011 | -0.78x | CN¥-408.49 Million | CN¥523.78 Million | ▼ -277.0% |
| 2010 | 0.44x | CN¥299.72 Million | CN¥680.08 Million | ▼ -0.4% |
| 2009 | 0.44x | CN¥318.21 Million | CN¥718.89 Million | ▼ -26.7% |
| 2008 | 0.60x | CN¥210.18 Million | CN¥347.88 Million | — |